Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
16 hedge funds and large institutions have $60.1M invested in Zealand Pharma A/S American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 4 closing their positions.
16% less funds holding
Funds holding: 19 → 16 (-3)
26% less capital invested
Capital invested by funds: $81.3M → $60.1M (-$21.2M)
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$699K |
| 2 |
JP Morgan Chase
New York
|
+$8.1K |
| 3 |
PA
Parallel Advisors
San Francisco,
California
|
+$1.28K |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
+$817 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.7M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$8.89M |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$1.52M |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$548K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$253K |
ZEAL Hedge Fund Activity: Q2 2020 in Review
16 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q2 2020, worth a combined $60.1M — down 26% from $81.3M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ZEAL and 1 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 3 added.
The largest buyer was Jane Street, adding an estimated $699K. The largest seller was Wellington Management Group, cutting an estimated $11.7M.
- 16 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q2 2020, down from 19 in Q1 2020.
- Funds reported $60.1M of Zealand Pharma A/S American Depositary Shares stock for Q2 2020, down 26% quarter-over-quarter.
- 1 fund opened new Zealand Pharma A/S American Depositary Shares positions in Q2 2020 and 4 closed out, a net change of -3 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q2 2020 was Jane Street, an estimated $699K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q2 2020 was Wellington Management Group, an estimated $11.7M sold.
Based on aggregated 13F filings for Q2 2020.